CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

IDEAYA Biosciences Advances IDE892 Into Phase 1/2 Monotherapy Expansion

Phase 1IDE892Positive
AI Analysis

Summary

IDEAYA Biosciences announced advancement of IDE892 into Phase 1/2 monotherapy expansion, representing clinical progress for the therapeutic candidate.

Clinical Trial Data

Phase

1/2

Importance:5/10
Sentiment:
0.50
clinical_developmentphase_advancementmonotherapy
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 11:05 AM

Read Original